AntalGenics
Neuropharmaceutical that eliminates the chronic itching of Psoriasis
AntalGenics has raised €808k across 1 funding round from 4 investors, most recently a Crowdfunding round in Feb 2022. Based in Elche, Spain; active in Healthtech. Data as of 28 Oct 2026.
Elche, Spainantalgenics.com ↗
Total raised
€808k
€808,000
Funding rounds
1
Investors
4
distinct backers
Active since
2022-02
latest 2022-02
Funding by year
EUR raised per yearAntalGenics — funding by year — interactive chart.
Data table
| AntalGenics — funding by year | |
|---|---|
| 2022 | €808k |
Signals
High confidenceRaise-next likelihood6
base rate 33% for Crowdfunding
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-16 | Crowdfunding | €808k | Antonio Ferrer,Antonio Parente,Capital Cell,Inveready | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData